Contact
Home • Our expertise • Centers of Excellence • Forecasting & Financial Modeling

Forecasting & Financial Modeling.

Drive smart business decisions across the product lifecycle.

Get in touch with a Forecasting & Financial Modeling expert

What we do.

We provide a full suite of forecasting and financial modeling services for pharmaceutical companies. Our technical forecasting expertise in both deterministic and probabilistic domains support a variety of stakeholders, helping inform strategic, tactical, and investment decisions.

Whether for full-service or plug-and-play support, we can help you simplify the complexities of pharmaceutical forecasting through technical excellence, therapeutic area expertise, and data analytics.

Learn about our services

Our Forecasting and Pharma Financial Modeling services include:

  • Pipeline long-range strategy forecasts
  • In-line product operational forecasts
  • Valuation modeling
  • Business development and licensing forecasts
  • Dynamic disease modeling
  • Portfolio modeling
  • Value, pricing, and access scenario modeling

Our Financial Modeling & Forecasting expertise.

Strategy

  • Forecast development spanning epidemiology, Rx, and volume-based to support LRP
  • Modeling to inform due diligence decisions and risk/non-risk adjusted valuations
  • Scenario planning models
  • Simulation and portfolio modeling

Operational

  • Trend based forecast modeling for in-line products to support manufacturing and tactical planning
  • Dynamic disease epidemiology modeling to capture patient flow dynamics
  • Payer and channel economics and contracting models

Data Analytics

  • Analysis of market data sets
  • Real world data analysis across EMR, claims, and registry
  • Proprietary disease landscape, epidemiology, and analog data sets to inform forecast assumptions

Get to know some of our experts.

Vikram Gosain

Partner

Read bio

Sumit Tiwari

Director

Read bio

Michael Harvey

Featured case study

Dynamic disease modeling in NSCLC.

Our client required a comprehensive view of patient opportunity by granular sub-segments through a sophisticated model covering various dynamics.
View all case studies
Featured

Dynamic disease modeling in NSCLC

The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.

Read more

Latest thinking.

Get the latest insights and perspectives from our experts.

View all of our resources

Dynamic disease modeling in NSCLC

The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.

Read more

CAR-T roundtable discussion

Putnam’s panel of CGT experts help the clients in clinical decision-making, product on-boarding, emerging technologies, and key market trends

Read more

Long-term strategy for Cellular Therapy

A large oncology company was looking to capitalize on early advantages in the cell therapy market. The organization engaged Putnam to support...

Read more

Unlocking the promise of Cell Therapies for solid tumors: Opportunities and challenges

Our cell and gene therapy experts offer a deep analysis on the current opportunities and challenges of cell therapies...

Read more

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Contact us today